Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech).

MLA

Andries, Jessica, et al. “Author Correction: The SARS-CoV-2 Spike Residues 616/644 and 1138/1169 Delineate Two Antibody Epitopes in COVID-19 MRNA COMIRNATY Vaccine (Pfizer/BioNTech).” Scientific Reports, vol. 12, no. 1, Apr. 2022, p. 6498. EBSCOhost, https://doi.org/10.1038/s41598-022-10885-7.

APA

Andries, J., Viranaicken, W., Cordonin, C., Herrscher, C., Planesse, C., Roquebert, B., Lagrange-Xelot, M., El-Kalamouni, C., Meilhac, O., Mavingui, P., Couret, D., Gadea, G., & Despres, P. (2022). Author Correction: The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech). Scientific Reports, 12(1), 6498. https://doi.org/10.1038/s41598-022-10885-7

Chicago

Andries, Jessica, Wildriss Viranaicken, Colette Cordonin, Charline Herrscher, Cynthia Planesse, Bénédicte Roquebert, Marie Lagrange-Xelot, et al. 2022. “Author Correction: The SARS-CoV-2 Spike Residues 616/644 and 1138/1169 Delineate Two Antibody Epitopes in COVID-19 MRNA COMIRNATY Vaccine (Pfizer/BioNTech).” Scientific Reports 12 (1): 6498. doi:10.1038/s41598-022-10885-7.